1. The "priced like tobacco?" screen — is the de-rating terminal or cyclical?
The repeatable method
- Flag a consumer-staples category whose leaders have de-rated to tobacco-like multiples — the market's shorthand for "structural, terminal, cigarette-style decline."
- Do not accept the label at face value. Ask the pivotal question: is the volume decline truly secular/terminal, or is it partly cyclical / affordability-driven and therefore recoverable?
- If a meaningful slice of the drop is cyclical, the tobacco multiple is mispriced — the de-rating overshot, and the gap between a terminal price and a merely-soft business is the opportunity.
Here: PRNDY now trades below BTI and MO on expected earnings, and DEO's multiple is at 2009 levels — a full tobacco valuation for spirits, which only makes sense if drinking is dying like smoking.
Watch for
- Categories the market has already written off; the historical premium (or discount) versus tobacco and how far it has compressed; whether the "terminal decline" narrative rests on a few scary datapoints (four down years) rather than proof of permanence.
2. Separate secular demand loss from priced-out demand — RTD/small-pack is the tell
The repeatable method
- List the secular pressures that would make the decline permanent: moderation, wellness, GLP-1 weight-loss drugs, legal substitutes (cannabis/THC, no/low-alcohol).
- Then hunt for a within-category signal that separates "can't afford it" from "don't want it": look at cheaper, smaller, or convenience formats. If those are booming while premium formats shrink, the consumer still wants the product — they're just budget-constrained.
- Weight the two: the larger the priced-out share, the more the sell-off is cyclical and the stronger the contrarian case.
Here: RTD canned cocktails are up 20–30%/yr and smaller packs outperform even as bottles fall — "Gen Z wants to drink." That points to squeezed budgets, not abstinence, undercutting the terminal-decline thesis behind the DEO/PRNDY de-rating.
Watch for
- Format-level growth rates (cans vs bottles, small vs large pack); who captures the cheap format and whether it's margin-accretive or dilutive; GLP-1 and no/low-alcohol penetration curves that would tip the balance back toward secular.
3. The on-premise vs off-premise price-gap diagnostic — locate where demand is breaking
The repeatable method
- Split the category's price inflation by channel — where it's consumed out (bars/restaurants) vs bought to consume at home (grocery/liquor store).
- A wide gap tells you the pain is concentrated in the expensive channel; if consumers were merely trading down they'd shift to the cheap channel, and total volume would hold.
- If total volume falls anyway despite a still-cheap home channel, the behavior change is real — but read which channel drove it before concluding the whole category is doomed.
Here: on-premise spirits prices are +29% over 5yr vs just +9% off-premise. $20 cocktails are pricing people out of bars — and unlike 2009–10, they're cutting back rather than drinking at home, which is what spooked the market.
Watch for
- Channel-level price and volume splits; whether an affordability fix (cheaper new products, smaller packs) can re-open the lost occasions; analogues to prior cycles (2009–10) where the trade-down cushioned volumes.
4. "Bad news priced in" — buy the de-rated leader with a growth engine and a catalyst
The repeatable method
- Once you judge the de-rating overshot, don't buy the whole sector — buy the leader whose valuation carries the most pessimism (the deepest de-rate).
- Require an offsetting growth engine the terminal-decline story ignores (a region or segment still compounding) so you're not solely reliant on the multiple re-rating.
- Require a near-term catalyst that can force a re-rate (new strategy, new leadership, new product) — bad news priced in plus a catalyst is the asymmetric entry.
Here: DEO is the pick over the sector — deepest de-rate (2009-level multiple), an offsetting emerging-market/India business still growing, and a catalyst in the new CEO's summer strategy (incl. cheaper products). PRNDY is the cheaper-still second name; the tobacco benchmarks (BTI, MO, PM) are just the yardstick.
Watch for
- Which name is most de-rated vs its own history; the size and growth of the offsetting engine; a dated catalyst on the calendar; position it as part of a balanced mix ("not the time to binge"), sizing for the chance the bear case is right.
5. When incumbents cede the growing format on margins, the beneficiary is the adjacent industry
The repeatable method
- When a category's only growing format carries lower margins for the incumbent, expect the incumbent to hesitate — protecting mix at the cost of share.
- Identify who has both the cost structure (existing assets) and the margin incentive to take it: often an adjacent industry for whom the same format is margin-accretive.
- Play the beneficiary, not the incumbent, for exposure to the growing format — and watch whether the incumbent eventually capitulates and enters (a signal, not a given).
Here: distillers ceded RTDs because cans earn less than bottles; brewers took them because cans are more lucrative than beer and they already own canning lines. BUD (via Cutwater) is the RTD beneficiary the distillers left on the table.
Watch for
- Format margin differentials by industry; existing asset overlap (canning, distribution); boom/bust risk in the format itself (craft beer, hard seltzers fizzled) that could make heavy incumbent investment a trap.